Jean-Claude Chermann

Last updated

Jean-Claude Chermann is a French virologist who managed the research team which, by 1983, under the administrative supervision of Luc Montagnier, had discovered the virus associated with AIDS. [1] Whereas second author of this initial publication and obviously involved as team manager in this discovery, he had been omitted from the Nobel Prize attributed to its colleagues. In 2008, as chairman of the support committee for the attribution of the Nobel Prize in medicine to Jean-Claude Chermann, Bernard Le Grelle, a political consultant, campaigned for the official recognition of this oversight with the Nobel committee by bringing together more than 700 doctors, professors and scientists (including professor Robert Gallo). [2] [3] [4] [5] [6] The virus was named lymphadenopathy-associated virus, or LAV. A year later, a team led by Robert Gallo of the United States confirmed the discovery of the virus, but renamed it human T-lymphotropic virus type III (HTLV-III). [7]

Related Research Articles

<span class="mw-page-title-main">HIV</span> Human retrovirus, cause of AIDS

The human immunodeficiency viruses (HIV) are two species of Lentivirus that infect humans. Over time, they cause acquired immunodeficiency syndrome (AIDS), a condition in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive. Without treatment, the average survival time after infection with HIV is estimated to be 9 to 11 years, depending on the HIV subtype.

<span class="mw-page-title-main">1983</span> Calendar year

1983 (MCMLXXXIII) was a common year starting on Saturday of the Gregorian calendar, the 1983rd year of the Common Era (CE) and Anno Domini (AD) designations, the 983rd year of the 2nd millennium, the 83rd year of the 20th century, and the 4th year of the 1980s decade.

<span class="mw-page-title-main">Nobel Prize in Physiology or Medicine</span> One of five Nobel Prizes established in 1895 by Alfred Nobel

The Nobel Prize in Physiology or Medicine is awarded yearly by the Nobel Assembly at the Karolinska Institute for outstanding discoveries in physiology or medicine. The Nobel Prize is not a single prize, but five separate prizes that, according to Alfred Nobel's 1895 will, are awarded "to those who, during the preceding year, have conferred the greatest benefit to humankind". Nobel Prizes are awarded in the fields of Physics, Chemistry, Physiology or Medicine, Literature and Peace.

<span class="mw-page-title-main">Human T-lymphotropic virus 1</span> Species of virus

Human T-cell lymphotropic virus type 1 or human T-lymphotropic virus (HTLV-I), also called the adult T-cell lymphoma virus type 1, is a retrovirus of the human T-lymphotropic virus (HTLV) family.

The year 1983 in science and technology involved many significant events, as listed below.

<span class="mw-page-title-main">Luc Montagnier</span> French virologist and Nobel laureate (1932–2022)

Luc Montagnier was a French virologist and joint recipient, with Françoise Barré-Sinoussi and Harald zur Hausen, of the 2008 Nobel Prize in Physiology or Medicine for his discovery of the human immunodeficiency virus (HIV). He worked as a researcher at the Pasteur Institute in Paris and as a full-time professor at Shanghai Jiao Tong University in China.

<span class="mw-page-title-main">History of HIV/AIDS</span> Epidemiological history

AIDS is caused by a human immunodeficiency virus (HIV), which originated in non-human primates in Central and West Africa. While various sub-groups of the virus acquired human infectivity at different times, the present pandemic had its origins in the emergence of one specific strain – HIV-1 subgroup M – in Léopoldville in the Belgian Congo in the 1920s.

The genome and proteins of HIV (human immunodeficiency virus) have been the subject of extensive research since the discovery of the virus in 1983. "In the search for the causative agent, it was initially believed that the virus was a form of the Human T-cell leukemia virus (HTLV), which was known at the time to affect the human immune system and cause certain leukemias. However, researchers at the Pasteur Institute in Paris isolated a previously unknown and genetically distinct retrovirus in patients with AIDS which was later named HIV." Each virion comprises a viral envelope and associated matrix enclosing a capsid, which itself encloses two copies of the single-stranded RNA genome and several enzymes. The discovery of the virus itself occurred two years following the report of the first major cases of AIDS-associated illnesses.

Donald Pinkston Francis is an American epidemiologist who worked on the Ebola outbreak in Africa in the late 1970s, and as an HIV/AIDS researcher. He retired from the U.S. Public Health Service in 1992, after 21 years of service. He lives in San Francisco, California.

This article lists events from the year 2008 in France.

<span class="mw-page-title-main">Robert Gallo</span> American biomedical researcher

Robert Charles Gallo is an American biomedical researcher. He is best known for his role in establishing the human immunodeficiency virus (HIV) as the infectious agent responsible for acquired immune deficiency syndrome (AIDS) and in the development of the HIV blood test, and he has been a major contributor to subsequent HIV research.

<span class="mw-page-title-main">History of virology</span> Aspect of history

The history of virology – the scientific study of viruses and the infections they cause – began in the closing years of the 19th century. Although Edward Jenner and Louis Pasteur developed the first vaccines to protect against viral infections, they did not know that viruses existed. The first evidence of the existence of viruses came from experiments with filters that had pores small enough to retain bacteria. In 1892, Dmitri Ivanovsky used one of these filters to show that sap from a diseased tobacco plant remained infectious to healthy tobacco plants despite having been filtered. Martinus Beijerinck called the filtered, infectious substance a "virus" and this discovery is considered to be the beginning of virology.

<span class="mw-page-title-main">Françoise Barré-Sinoussi</span> French virologist and Nobel laureate (born 1947)

Françoise Barré-Sinoussi is a French virologist and Director of the Regulation of Retroviral Infections Division and Professor at the Institut Pasteur in Paris, France. Born in Paris, France, Barré-Sinoussi performed some of the fundamental work in the identification of the human immunodeficiency virus (HIV) as the cause of AIDS. In 2008, Barré-Sinoussi was awarded the Nobel Prize in Physiology or Medicine, together with her former mentor, Luc Montagnier, for their discovery of HIV. She mandatorily retired from active research on August 31, 2015, and fully retired by some time in 2017.

<span class="mw-page-title-main">Primate T-lymphotropic virus</span> Informal grouping of virus species

The primate T-lymphotropic viruses (PTLVs) are a group of retroviruses that infect primates, using their lymphocytes to reproduce. The ones that infect humans are known as human T-lymphotropic virus (HTLV), and the ones that infect Old World monkeys are called simian T-lymphotropic viruses (STLVs). PTLVs are named for their ability to cause adult T-cell leukemia/lymphoma, but in the case of HTLV-1 it can also cause a demyelinating disease called tropical spastic paraparesis. On the other hand, newer PTLVs are simply placed into the group by similarity and their connection to human disease remains unclear.

<span class="mw-page-title-main">Willy Rozenbaum</span> French physician (born 1945)

Willy Rozenbaum is a Polish-born French physician.

<i>Continuum</i> (magazine) Magazine featuring AIDS denialism

Continuum was a magazine published by an activist group of the same name who denied the existence of HIV/AIDS.

<span class="mw-page-title-main">William A. Haseltine</span> American biologist (born 1944)

William A. Haseltine is an American scientist, businessman, author, and philanthropist. He is known for his groundbreaking work on HIV/AIDS and the human genome.

<span class="mw-page-title-main">Jacques Leibowitch</span> French physician and researcher (1942–2020)

Jacques Leibowitch was a French medical doctor and clinical researcher known for his contributions to the knowledge and treatment of HIV and AIDS, starting with his initial designation of a human retrovirus as the cause of AIDS, and his ground-breaking use of triple combination therapy for the effective control of HIV in the patient. A practicing physician in the infectiology department of the Raymond Poincaré University Hospital of Garches, University lecturer Emeritus, he led the treatment program ICCARRE that proposes a dramatic reduction of weekly anti-HIV drug intake, down to 2-3 anti-viral pills a day taken 2 to 3 or 4 days a week, as opposed to the presently recommended seven days a week, as still universally prescribed. These reduced medical dosages are adequate, necessary and sufficient according to the results of his exploratory clinical research carried out since 2003. He is the author of the books "Un virus étrange venu d'ailleurs", and "Pour en finir avec le sida".

HPA-23, sometimes known as antimonium tungstate, is an antiretroviral drug that was used for the treatment of HIV infection. It achieved widespread publicity as an effective treatment for HIV and AIDS beginning in 1984, just one year after HIV was first identified. Later testing failed to demonstrate any efficacy and some patients suffered serious side effects from the drug, including liver failure.

<span class="mw-page-title-main">Bernard Le Grelle</span> Belgian investigative journalist and political consultant

Bernard le Grelle is a Belgian investigative journalist, political adviser, author, former United Nations expert and public affairs executive. He is known for his long-term investigation into the 1963, John F. Kennedy assassination. He is a member of the noble Le Grelle family.

References

  1. Barré-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vézinet-Brun F, Rouzioux C, Rozenbaum W, Montagnier L (1983). "Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)". Science. 220 (4599): 868–871. Bibcode:1983Sci...220..868B. doi:10.1126/science.6189183. PMID   6189183.
  2. Zyserman, Isabelle (November 4, 2016). Pourquoi le " 3e mousquetaire " n'a pas eu le Nobel de médecine ?. L'Obs avec Rue89.
  3. Bhattacharjee, Yudhijit (December 19, 2008). Face offs: Chermann "taught Barré-Sinoussi everything she knew" and was instrumental in the discovery, says Bernard Le Grelle, a financial consultant who has set up a support committee for his slighted friend. Science Vol n°322.
  4. Mennessier, Marc (October 10, 2008). " L'amertume des " oubliés " du prix Nobel ". Le Figaro.
  5. Article Le Figaro « Sarkozy décore un « oublié » du Nobel », 1er juillet 2009
  6. Article Jean-Claude Chermann, l’oublié du Prix Nobel de médecine décoré par Nicolas Sarkozy
  7. Popovic M, Sarngadharan MG, Read E, Gallo RC (1984). "Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS". Science. 224 (4648): 497–500. Bibcode:1984Sci...224..497P. doi:10.1126/science.6200935. PMID   6200935.